Among the tumor types with a high frequency of STAG2 mutation, STAG2‐mutant uterine corpus endometrial carcinomas (UCEC) showed a significant increase in KMT5A expression compared to STAG2‐proficient UCECs (Figure S6C, Supporting Information). This evidence concerns the gene STAG2 and uterine corpus endometrial carcinoma.